In vitro evaluation of Taxol combined with radiations in human squamous cell carcinoma spheroids.

Date publication

décembre 1996

Journal

Cancer letters

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MERLIN Jean-Louis

Tous les auteurs :
Griffon-Etienne G, Merlin JL, Marchal C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/9020899

Résumé

The effect of Taxol on the radiation sensitivity of human squamous carcinoma of the head and neck region was determined in vitro, using clonogenic assays and multicellular tumor spheroids (MTS). Radiosensitivity parameters were determined by alpha and beta for clonogenic assays, and by the residual/control volume ratios at 2 Gy (RSV2) and the dose inducing 50% decrease in MTS number (SCD50) for spheroids. In HTB43 and CAL27 colonies, the combination was antagonist. In spheroids, Taxol induced a decrease of RSV2 and SCD50 in HTB43 and CAL27 MTS and their combinations with radiation were synergistic and additive, respectively. Therefore, the different results obtained by clonogenic assays and MTS may suggest higher drug incorporation through the multiple cell layers of the spheroids than in monolayers.

Mots clés

Antineoplastic Agents, Phytogenic, pharmacology, Carcinoma, Squamous Cell, radiotherapy, Dose-Response Relationship, Radiation, Head and Neck Neoplasms, radiotherapy, Humans, Paclitaxel, pharmacology, Radiation Tolerance, drug effects, Radiation-Sensitizing Agents, pharmacology, Spheroids, Cellular, drug effects, Tumor Cells, Cultured, drug effects

Référence

Cancer Lett.. 1996 Dec;109(1-2):23-32